Alkeran
Showing 26 - 50 of 187
Hematologic Malignancy, Bone Marrow Transplant Trial in New York (Tocilizumab, Fludarabine, Melphalan)
Recruiting
- Hematologic Malignancy
- Bone Marrow Transplant
- Tocilizumab
- +4 more
-
New York, New YorkWeill Cornell Medical College
Oct 27, 2021
Myeloma Trial in Little Rock (Melphalan, Velcade, Thalidomide)
Active, not recruiting
- Myeloma
- Melphalan
- +7 more
-
Little Rock, ArkansasUniversity of Arkansas for Medical Sciences
Dec 1, 2021
Multiple Myeloma Trial in Berne (Melphalan, Bendamustine)
Completed
- Multiple Myeloma
-
Berne, SwitzerlandDepartment for Medical Oncology University Hospital/Inselspital
Jul 29, 2021
Leukemia, Erythroblastic, Acute, MDS Trial in New York (5-Azacytidine, Fludarabine, Melphalan)
Completed
- Leukemia, Erythroblastic, Acute
- Myelodysplastic Syndromes
- 5-Azacytidine
- +4 more
-
New York, New YorkWeill Cornell Medical College
Aug 25, 2021
MDS, Leukemia, Myeloid, Acute, Leukemia, Relapsed Adult Acute Myeloid Trial in New York (CPX-351, Fludarabine, Melphalan)
Active, not recruiting
- Myelodysplastic Syndromes
- +3 more
- CPX-351
- +4 more
-
New York, New YorkWeill Cornell Medical College
Jan 26, 2022
Primary Systemic Amyloidosis, Light Chain Deposition Disease Trial in United States (drug, genetic, other, procedure)
Active, not recruiting
- Primary Systemic Amyloidosis
- Light Chain Deposition Disease
- bortezomib
- +6 more
-
Denver, Colorado
- +6 more
Aug 24, 2022
Recurrent Adult Hodgkin Lymphoma Trial in Duarte (biological, drug, other, procedure)
Active, not recruiting
- Recurrent Adult Hodgkin Lymphoma
- basiliximab
- +8 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 17, 2022
Multiple Myeloma Trial in Little Rock (Velcade, Melphalan, Thalidomide)
Active, not recruiting
- Multiple Myeloma
- Velcade
- +7 more
-
Little Rock, ArkansasUniversity of Arkansas for Medical Sciences
Sep 7, 2021
Leukemia, MDS, Childhood Acute Myeloid Leukemia in Remission Trial in Minneapolis (biological, drug, procedure)
Recruiting
- Leukemia
- +12 more
- filgrastim
- +6 more
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Jan 20, 2022
Adult Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult
Active, not recruiting
- Adult Acute Lymphoblastic Leukemia in Remission
- +6 more
- clofarabine
- +5 more
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 17, 2022
Multiple Myeloma Trial in Maywood (Carfilzomib, Busulfan IV, Melphalan IV)
Recruiting
- Multiple Myeloma
- Carfilzomib
- +2 more
-
Maywood, IllinoisLoyola University Medical Center
Apr 23, 2021
Lymphoma, HIV Trial in United States (Autologous transplant, BCNU, Etoposide)
Completed
- Lymphoma
- HIV
- Autologous transplant
- +4 more
-
Duarte, California
- +15 more
Dec 6, 2022
GVHD, Leukemia, Lymphoma Trial in Duarte (biological, drug, procedure, radiation, other)
Active, not recruiting
- Graft Versus Host Disease
- +2 more
- rituximab
- +8 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 17, 2022
Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid
Recruiting
- Previously Treated Myelodysplastic Syndrome
- +3 more
- Fludarabine Phosphate
- +9 more
-
Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
Jan 7, 2022
Autologous Hematopoietic Stem Cell Transplant Recipient, Loss of Chromosome 17p, Plasma Cell Leukemia Trial in Duarte (drug,
Active, not recruiting
- Autologous Hematopoietic Stem Cell Transplant Recipient
- +4 more
- bortezomib
- +7 more
-
Duarte, CaliforniaCity of Hope
Mar 17, 2022
GVHD, AML, ALL Trial in Boston (FLUDARABINE, CYCLOPHOSPHAMIDE, TBI)
Recruiting
- GVHD
- +15 more
- FLUDARABINE
- +6 more
-
Boston, MassachusettsMassachusetts General Hospital
Sep 30, 2021
Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), MDS (MDS) Trial in Memphis (drug, biological, device)
Recruiting
- Acute Lymphoblastic Leukemia (ALL)
- +7 more
- Cyclophosphamide
- +11 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Oct 8, 2021
Multiple Myeloma Trial in United States (procedure, drug, biological)
Completed
- Multiple Myeloma
- Tumor Cell Collection
- +6 more
-
San Francisco, California
- +14 more
Jul 11, 2022
Retinoblastoma Trial in France (Melphalan or Melphalan + Topotecan, etoposide, carboplatin and vincristine, Carboplatin
Recruiting
- Retinoblastoma
- Melphalan or Melphalan + Topotecan
- +6 more
-
Saint-Denis, La Réunion, France
- +27 more
Nov 24, 2022
Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Trial in New York (Bendamustine, Carmustine, Etoposide)
Completed
- Hodgkin's Lymphoma
- Non-Hodgkin's Lymphoma
- Bendamustine
- +8 more
-
New York, New YorkWeill Cornell Medical College
Feb 1, 2021
Multiple Myeloma Trial in Baltimore (biological, drug, procedure)
Completed
- Multiple Myeloma
- Activated marrow infiltrating lymphocytes
- +6 more
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mar 16, 2021
Acute Myeloid Leukemia in Remission, MDS, Chronic Myeloid Leukemia in Remission Trial in Belgium (Thymoglobulin, Melphalan,
Recruiting
- Acute Myeloid Leukemia in Remission
- +9 more
- Thymoglobulin
- +3 more
-
Antwerp, Belgium
- +9 more
Oct 5, 2021